Rush University Medical Center is a nationally ranked academic medical center in the Illinois Medical District neighborhood of Chicago, Illinois.

There are 664 beds in Rush University Medical Center (2702).

During the past decade, Rush University Medical Center (2702) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University Medical Center (2702)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator and "Exegi Pharma, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rush University Medical Center (2702)" are "HIV Infections" (4 trials), "HIV-1 Infection" (2 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Rush University Medical Center (2702)" in a lesser frequency.

Most popular intervention types in "Rush University Medical Center (2702)" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (2 trials), "Abacavir sulfate, Lamivudine and Zidovudine" (1 trials), "Atazanavir" (1 trials), "Calcium Carbonate" (1 trials) and "Cyclosporine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush University Medical Center (2702)" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Rush University Medical Center (2702)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Rush University Medical Center (2702), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush University Medical Center (2702), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".